Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Zentalis Pharmaceuticals granted 191,000 non-qualified stock options to two newly hired employees. The grants were made under Nasdaq Listing Rule 5635(c)(4) as an inducement material to their employment.
Key figures
- Offering Price
- 3.98
- Shares Offered
- 191000
- Term
- 10 years
- Grant type
- non-qualified stock options
- Vesting period
- 4 years
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.